The Combined First Trimester Screening
1 other identifier
observational
2,000
1 country
3
Brief Summary
The project is a national, prospective, multicenter pilot project. The project is focus on setting up the combined first trimester screening in the Czech Republic. The combined first trimester screening is aimed at predicting and detecting the most serious obstetric complications, such as the great obstetrical syndromes (preeclampsia, fetal growth restriction, preterm labor and intrauterine fetal demise "IUFD") and structural congenital defects (morphological and chromosomal). The primary objective of the project is to create a unified methodology for performing and evaluating the combined first trimester screening in connection with the National Health Information System (hereinafter referred to as "NHIS"), which will enable recording, providing analysis and linking recorded clinical parameters with data in the NHIS. The pilot project will also provide data for modeling appropriate mechanisms for reimbursement from public health insurance.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2025
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 3, 2025
CompletedFirst Posted
Study publicly available on registry
June 11, 2025
CompletedStudy Start
First participant enrolled
June 15, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 30, 2027
April 17, 2026
April 1, 2026
1.4 years
June 3, 2025
April 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Proportion of women with identified increased risk of Preeclampsia, Fetal Growth Restriction or Fetal Chromosomal Aneuploidies (trisomies of chromosomes 21, 18 and 13)
From June 2025 to October 2026
Study Arms (1)
A woman over 18 years old in the first trimester of pregnancy (11th-13th gestational week)
A participant in the project must have signed the Consent to Participate in the Project and the Consent to the Processing of Personal Data.
Eligibility Criteria
Pregnant women matching all inclusion criteria \& GDPR.
You may qualify if:
- A woman over 18 years old in the first trimester of pregnancy (11th-13th gestational week)
- Signed the Consent to Participate in the Project and GDPR.
You may not qualify if:
- Unsigned the Consent to Participate in the Project and the Consent to the Processing of Personal Data.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Regional Health Corpotarion - Most Hospital
Most, Czechia, Czechia
University Hospital Olomouc
Olomouc, Czechia, Czechia
Institute for the Care of Mother and Child
Prague, Czechia, Czechia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Marek Ľubušký, prof.
THE FETAL MEDICINE CENTRE, Department of Obstetrics and Gynecology, Palacky University Olomouc, Faculty of Medicine and Dentistry, University Hospital Olomouc
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 3, 2025
First Posted
June 11, 2025
Study Start
June 15, 2025
Primary Completion (Estimated)
October 31, 2026
Study Completion (Estimated)
April 30, 2027
Last Updated
April 17, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share